Miles Darrin 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2021-02-14+8,666→ 14,541 total - Exercise/Conversion
Common stock
2021-02-16+922→ 15,463 total - Tax Payment
Common stock
2021-02-16−2,916→ 12,547 total - Exercise/Conversion
Restricted stock units
2021-02-16−922→ 0 total→ Common stock (922 underlying) - Exercise/Conversion
Restricted stock units
2021-02-14−8,666→ 17,334 total→ Common stock (8,666 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units vest in three equal annual installments.